Through the last few years, many high-profile scientific regions were scattered around Europe. Being fully aware of the importance of those collaborations, EuroBioForum worked on a thorough research audit on the Bioregion and cluster landscape in Europe. The recent update of the EuroBioForum Observatory – publicly available database presenting the key initiatives in Personalised Medicine – features 28 bioregions and clusters in Europe. We aspire that biotechnology sector in Europe will become even more competitive and at the same time more concrete, by sharing the best practices between bio-communities.
Recently, much progress has been made in identifying and validating new biomarkers in population-based studies. Biomarkers are tests that can be used to follow body processes and diseases in humans and animals. They can be used to predict how a patient will respond to a medicine or whether they have, or are likely to develop, a certain disease.
The European Personalised Medicine Association (EPEMED) announced recently the 2013 Spring series of webinars addressing the key issues shaping the personalised medicine space. Dr Wouter Spek, Managing director of EuroBioForum, will kick-off with inaugural web session on 24 April 2013 titled: ‘How to tackle the future challenges in Personalised Medicine in Europe?’
This year the EuroBioForum 2nd Annual Conference will explore the potential areas for transnational and transregional collaboration. Leading experts will offer insight into current developments in their countries and regions.